Lantern Pharma Expands predictBBB AI Into Real-Time Large Quantitative Model for Global Drug Discovery
Lantern Pharma announced that its predictBBB.ai platform has evolved into a Large Quantitative Model (LQM), transforming it into a real-time molecular intelligence system for small-molecule drug discovery. The upgraded platform allows researchers to input a single SMILES string and instantly generate a full 360-degree developability profile, analyzing dozens of physicochemical and structural properties in seconds. Delivered as a web-based service, the system is designed to make advanced computational drug design tools more accessible to biotech, academic, and pharmaceutical researchers worldwide while accelerating early-stage drug development workflows. 
Lantern Pharma Expands predictBBB AI Into Real-Time Large Quantitative Model for Global Drug Discovery